A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
- Conditions
- Pregnant HIV Positive Women
- Registration Number
- NCT00341302
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Brief Summary
By the end of 1999, it was estimated that 1.2 million children were living with HIV infection. During 1999 alone, 600,000 children were newly infected with HIV, mostly in less-developed countries. Most HIV-infected children are infected by transmission from mother to child during pregnancy, at birth, or through breast milk. Antiretroviral medications, cesarean section before rupture of membranes, and avoidance of breastfeeding are ways to reduce the risk of transmission. This study will determine mother-to-child transmission rates and the effects on infants of exposure to antiretroviral medications and mode of delivery.
Approximately 180 to 240 HIV-infected pregnant women in Mexico and Argentina will be enrolled during the first year of this 5-year study. HIV-infected women will be evaluated during pregnancy, during delivery, and 6 months after delivery. At each visit, a history will be taken and physical examination given; blood will be collected for laboratory tests.
HIV-exposed infants will be evaluated through 6 months of age. At each of 2 visits, a history will be taken and physical examination given; blood will be collected for laboratory tests; and growth will be assessed.
- Detailed Description
This is an observational, prospective cohort study to describe the characteristics of HIV-infected pregnant women and HIV-exposed, uninfected children at participating clinical sites in Latin America where the following are available: 1) antiretrovirals (ARVs) for treatment of HIV-infected women and for prevention of mother-to-child transmission (MTCT) of HIV; and 2) infant formula. We will describe the utilization of interventions related to decreasing the risk of MTCT, including ARV prophylaxis, cesarean section before labor and before ruptured membranes, and complete avoidance of breastfeeding. We will describe receipt of maternal ARV regimens and determine rates of MTCT of HIV. This study will describe maternal adverse events during pregnancy and the postpartum period. In addition, the study will describe child outcomes potentially related to in utero and early postnatal exposure to ARVs. HIV-infected women will be evaluated antepartum, intrapartum, 6 months postpartum and then every 6 months for up to 5 years after delivery. HIV-exposed, uninfected children will be evaluated for up to 5 years of follow-up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 3554
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To describe the characteristics of HIV-infected pregnant women and their HIV-exposed children in Latin America, including the rates of and risk factors for mother-to-child transmission in utero, six weeks To describe the characteristics of HIV-infected pregnant women and their HIV-exposed children in Latin America, including the rates of and risk factors for mother-to-child transmission.
To characterize adverse events according to receipt of and exposure to ARVs (by HIV- infected women during pregnancy and postpartum and by their HIV-exposed but uninfected children in utero and during the first few week in utero, six weeks To characterize adverse events according to receipt of and exposure to ARVs (by HIV- infected women during pregnancy and postpartum and by their HIV-exposed but uninfected children in utero and during the first few week
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (12)
Hospital General de Agudos "Jose Maria Ramos Mejia"
🇦🇷Buenos Aires, Argentina
Unversity of San Marcos
🇵🇪Lima, Peru
Hospital Geral Nova de Iguacu Setor De DST/AIDS
🇧🇷Nova Iguacu, Brazil
Universidade de Caxias do Sul
🇧🇷Caxias do Sul, Brazil
Irmandade Da Santa Casa de Misericordia de
🇧🇷Porto Alegre, Brazil
Hospital Femina
🇧🇷Porto Alegre, Brazil
Hospital dos Servidores do Estado - RJ
🇧🇷Rio de Janeiro, Brazil
Instituto de Puericultura e Pediatria
🇧🇷Rio de Janeiro, Brazil
Hospital das Clinicas da Falculdade De Medinica
🇧🇷Sao Paulo, Brazil
Federal University of Sao Paulo-Escola Paulista de Medicina
🇧🇷Sao Paulo, Brazil
Universidade Federal de Minas Gerais
🇧🇷Minas Gerais, Brazil
Hospital Conceicao
🇧🇷Porto Alegre, Brazil